Cargando…

The newest TRP channelopathy: Gain of function TRPM3 mutations cause epilepsy and intellectual disability

Transient Receptor Potential Melastatin 3 (TRPM3) is a Ca(2+) permeable nonselective cation channel, activated by heat and chemical agonists, such as the endogenous neuro-steroid Pregnenolone Sulfate (PregS) and the chemical compound CIM0216. TRPM3 is expressed in peripheral sensory neurons of the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Siyuan, Rohacs, Tibor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057083/
https://www.ncbi.nlm.nih.gov/pubmed/33853504
http://dx.doi.org/10.1080/19336950.2021.1908781
_version_ 1783680769517944832
author Zhao, Siyuan
Rohacs, Tibor
author_facet Zhao, Siyuan
Rohacs, Tibor
author_sort Zhao, Siyuan
collection PubMed
description Transient Receptor Potential Melastatin 3 (TRPM3) is a Ca(2+) permeable nonselective cation channel, activated by heat and chemical agonists, such as the endogenous neuro-steroid Pregnenolone Sulfate (PregS) and the chemical compound CIM0216. TRPM3 is expressed in peripheral sensory neurons of the dorsal root ganglia (DRG), and its role in noxious heat sensation in mice is well established. TRPM3 is also expressed in a number of other tissues, including the brain, but its role there has been largely unexplored. Recent reports showed that two mutations in TRPM3 are associated with a developmental and epileptic encephalopathy, pointing to an important role of TRPM3 in the human brain. Subsequent reports found that the two disease-associated mutations increased basal channel activity, and sensitivity of the channel to activation by heat and chemical agonists. This review will discuss these mutations in the context of human diseases caused by mutations in other TRP channels, and in the context of the biophysical properties and physiological functions of TRPM3.
format Online
Article
Text
id pubmed-8057083
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-80570832021-05-03 The newest TRP channelopathy: Gain of function TRPM3 mutations cause epilepsy and intellectual disability Zhao, Siyuan Rohacs, Tibor Channels (Austin) Review Transient Receptor Potential Melastatin 3 (TRPM3) is a Ca(2+) permeable nonselective cation channel, activated by heat and chemical agonists, such as the endogenous neuro-steroid Pregnenolone Sulfate (PregS) and the chemical compound CIM0216. TRPM3 is expressed in peripheral sensory neurons of the dorsal root ganglia (DRG), and its role in noxious heat sensation in mice is well established. TRPM3 is also expressed in a number of other tissues, including the brain, but its role there has been largely unexplored. Recent reports showed that two mutations in TRPM3 are associated with a developmental and epileptic encephalopathy, pointing to an important role of TRPM3 in the human brain. Subsequent reports found that the two disease-associated mutations increased basal channel activity, and sensitivity of the channel to activation by heat and chemical agonists. This review will discuss these mutations in the context of human diseases caused by mutations in other TRP channels, and in the context of the biophysical properties and physiological functions of TRPM3. Taylor & Francis 2021-04-14 /pmc/articles/PMC8057083/ /pubmed/33853504 http://dx.doi.org/10.1080/19336950.2021.1908781 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Zhao, Siyuan
Rohacs, Tibor
The newest TRP channelopathy: Gain of function TRPM3 mutations cause epilepsy and intellectual disability
title The newest TRP channelopathy: Gain of function TRPM3 mutations cause epilepsy and intellectual disability
title_full The newest TRP channelopathy: Gain of function TRPM3 mutations cause epilepsy and intellectual disability
title_fullStr The newest TRP channelopathy: Gain of function TRPM3 mutations cause epilepsy and intellectual disability
title_full_unstemmed The newest TRP channelopathy: Gain of function TRPM3 mutations cause epilepsy and intellectual disability
title_short The newest TRP channelopathy: Gain of function TRPM3 mutations cause epilepsy and intellectual disability
title_sort newest trp channelopathy: gain of function trpm3 mutations cause epilepsy and intellectual disability
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057083/
https://www.ncbi.nlm.nih.gov/pubmed/33853504
http://dx.doi.org/10.1080/19336950.2021.1908781
work_keys_str_mv AT zhaosiyuan thenewesttrpchannelopathygainoffunctiontrpm3mutationscauseepilepsyandintellectualdisability
AT rohacstibor thenewesttrpchannelopathygainoffunctiontrpm3mutationscauseepilepsyandintellectualdisability
AT zhaosiyuan newesttrpchannelopathygainoffunctiontrpm3mutationscauseepilepsyandintellectualdisability
AT rohacstibor newesttrpchannelopathygainoffunctiontrpm3mutationscauseepilepsyandintellectualdisability